Analyst Job at Amgen – Epidemiology Analyst Role in Hyderabad
Looking for an exciting analyst job in the biotechnology sector? Amgen is hiring an Epidemiology Analyst in Hyderabad, India, under its Center for Observational Research (CfOR). This opportunity is ideal for professionals with experience in observational research, real-world data (RWD), and epidemiology who are looking to grow with global Amgen careers and explore high-impact MBBS jobs in research and drug development.
Job Details:
- Job Position: Epidemiology Analyst
- Job ID: R-236957
- Location: Hyderabad
- Category: Research
About the Company:
Amgen is a leading global biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics. With a strong presence worldwide, Amgen uses advanced science and data analytics to transform medicine and improve patient outcomes. The company is recognized for its commitment to research excellence, drug development, and life-saving therapies across multiple therapeutic areas. Professionals exploring Amgen careers gain exposure to cutting-edge research, global collaborations, and impactful healthcare innovation.
Job Description:
Amgen is seeking an Epidemiology Analyst to join the organization based in Hyderabad, India. In this analyst job, the individual will contribute to research activities in the Data and Analytics Center (DAC) on functionally aligned teams. The ideal candidate should have strong knowledge of observational research methodology, excellent communication skills, attention to detail, and the ability to work across various therapeutic areas and regions. This role is an excellent opportunity for professionals seeking jobs in Hyderabad within global pharmaceutical research environments.
Qualifications:
- MBBS (or equivalent)
- Experience in the design, execution, and analysis of observational research studies within a Pharmaceutical or Public Health setting.
- Advanced expertise in medical codelist construction, maintenance, and quality assurance across standard clinical coding systems (e.g., ICD, MedDRA, SNOMED).
- Experience in research to support drug development.
- Experience working with secondary data systems, including administrative claims, EMR, and registries.
- Experience in observational research project planning and management.
- Excellent verbal and writing communication and interpersonal skills.
- Experience working in multi-disciplinary teams.
Key Responsibilities:
- Contribute to global observational research activities for CfOR in support of drug development, registration, and commercialization across Amgen’s portfolio of products.
- Contribute to the implementation and conduct of observational studies to support the product lifecycle using real-world databases and analytics platforms (e.g., Atlas, Aetion, and other internal/external RWD tools).
- Develop, review, and maintain high-quality medical codelists for exposures, outcomes, covariates, and safety endpoints using standard coding systems (e.g., ICD, MedDRA, SNOMED, RxNorm), ensuring clinical validity and regulatory readiness.
- Partner with study team members to ensure codelists are fit-for-purpose, transparent, and reproducible across studies.
- Executes/manages descriptive epidemiologic studies to characterize the incidence/prevalence of disease in the US, EU, Asia, and emerging market countries.
- Executes/manages research projects involving the analysis of multiple types of data, including medical claims, electronic health records, and prospective observational cohort studies.
- Provides safety research support across the life cycle of Amgen products, supports the development of risk management plans, and executes pharmacovigilance studies.
- Conducts literature reviews and prepares research reports and scientific manuscripts.
- Stays abreast of the latest developments in the field of observational research and drug development.
- Promotes awareness, understanding, and use of observational research methods.
- Communicates significant scientific information to a variety of audiences.
